PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset

Active filters

  • Chemical substance: Lidocaine
Presentation Product Chemical substance Chapter Items dispensed
Lidocaine 5% ointment
1502010I0AAAEAE
Lidocaine (Local Anaesthesia) Lidocaine Anaesthesia 13,591
Lidocaine 2% cream
1303000N0AAABAB
Lido (Topical Local Anaesthesia) Lidocaine Skin 4,061
Vagisil 2% medicated cream
1303000N0BDAAAB
Vagisil Lidocaine Skin 2,977
Xylocaine 10mg/dose spray
1502010I0BCABAC
Xylocaine (Ointment/Spray) Lidocaine Anaesthesia 2,790
Lidocaine 4% cream
1502010I0AAAKAK
Lidocaine (Local Anaesthesia) Lidocaine Anaesthesia 2,628
Lidocaine 10% spray sugar free
1502010I0AAACAC
Lidocaine (Local Anaesthesia) Lidocaine Anaesthesia 1,689
LMX 4 cream
1502010I0BGAAAK
LMX Lidocaine Anaesthesia 588
Lidocaine 0.5% ointment
1502010I0AAAMAM
Lidocaine (Local Anaesthesia) Lidocaine Anaesthesia No data available
Lidocaine 1% ointment
1502010I0AAAHAH
Lidocaine (Local Anaesthesia) Lidocaine Anaesthesia No data available
Lidocaine 25mg/Prilocaine 25mg/g gel 1.7g with applicator SF
1502010I0AAAJAJ
Lidocaine (Local Anaesthesia) Lidocaine Anaesthesia No data available
Lidocaine 25mg/Prilocaine 25mg/g periodontal gel 1.7g SF
1502010I0AAAIAI
Lidocaine (Local Anaesthesia) Lidocaine Anaesthesia No data available
Lidoderm 5% patches
1502010I0BEAAAG
Lidoderm Lidocaine Anaesthesia No data available
LMX 4 cream with Tegaderm dressing 10cm x 6cm
1502010I0BGABAK
LMX Lidocaine Anaesthesia No data available
Oraqix 25mg/25mg/g periodontal gel 1.7g cart with dispenser
1502010I0BFABAJ
Oraqix Lidocaine Anaesthesia No data available
Oraqix 25mg/25mg/g periodontal gel 1.7g cartridges
1502010I0BFAAAI
Oraqix Lidocaine Anaesthesia No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.